Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY1 | P47900 | 5/20 | 1.00 |
| ▸ | P2RY2 | P41231 | 3/20 | 1.00 |
| ▸ | SRC | P12931 | 2/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 1.00 |
| ▸ | TRPM2 | O94759 | 2/20 | 1.00 |
| ▸ | TAS1R3 | Q7RTX0 | 2/20 | 1.00 |
| ▸ | TAS1R1 | Q7RTX1 | 2/20 | 1.00 |
| ▸ | DNPH1 | O43598 | 1/20 | 1.00 |
| ▸ | PRKAB2 | O43741 | 1/20 | 1.00 |
| ▸ | LDHA | P00338 | 1/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 1/20 | 1.00 |
| ▸ | FBP1 | P09467 | 1/20 | 1.00 |
| ▸ | ADORA1 | P30542 | 1/20 | 1.00 |
| ▸ | PRKAG1 | P54619 | 1/20 | 1.00 |
| ▸ | PRKAA2 | P54646 | 1/20 | 1.00 |
| ▸ | PDE4D | Q08499 | 1/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 1/20 | 1.00 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 1.00 |
| ▸ | PDE3A | Q14432 | 1/20 | 1.00 |
| ▸ | P2RY11 | Q96G91 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine Phosphate SCHEMBL1338615 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL14478782 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL144997 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL13374692 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL15646670 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL18785114 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL8572634 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL5588 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Vidarabine Phosphate SCHEMBL144996 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 | |
| Adenosine Phosphate SCHEMBL13170051 | 1.00 | P2RY1 (1.00) | P2RY1P2RY2SRCSMN1; SMN2TRPM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230332333-A1 | ARRAY, SOAKING SOLUTIONS AND METHOD OF SELECTING SOAKING CONDITIONS FOR SMALL MOLECULES IN BIOLOGICAL MACROMOLECULAR CRYSTALS | CRYSTALSFIRST GMBH (DE) | 2023-10-19 | — | — | US | disclosed |
| US-20230323565-A1 | ARRAY, SOAKING SOLUTIONS AND METHOD OF SELECTING SOAKING CONDITIONS FOR SMALL MOLECULES IN BIOLOGICAL MACROMOLECULAR CRYSTALS | CRYSTALSFIRST GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| EP-4211463-A1 | ARRAY, SOAKING SOLUTIONS AND METHOD OF SELECTING SOAKING CONDITIONS FOR SMALL MOLECULES IN BIOLOGICAL MACROMOLECULAR CRYSTALS | CrystalsFirst GmbH (DE) | 2023-07-19 | — | — | EP | disclosed |
| EP-4211464-A1 | ARRAY, SOAKING SOLUTIONS AND METHOD OF SELECTING SOAKING CONDITIONS FOR SMALL MOLECULES IN BIOLOGICAL MACROMOLECULAR CRYSTALS | CrystalsFirst GmbH (DE) | 2023-07-19 | — | — | EP | disclosed |
| US-20230054895-A1 | METHODS FOR INDUCING BIOSTASIS IN A CELL, TISSUE OR ORGAN | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-02-23 | — | — | US | disclosed |
| US-20120114596-A1 | TSLP PROMOTES IMMUNE EVASION AND PERSISTENCE OF VIRUSES | INSTITUT CURIE (FR) | 2012-05-10 | — | — | US | disclosed |
| EP-2391649-A1 | TSLP PROMOTES IMMUNE EVASION AND PERSISTENCE OF VIRUSES | Institut Curie (FR) | 2011-12-07 | — | — | EP | disclosed |
| WO-2010086445-A1 | TSLP PROMOTES IMMUNE EVASION AND PERSISTENCE OF VIRUSES | INSTITUT CURIE (FR) | 2010-08-05 | — | — | WO | disclosed |
| EP-2213682-A1 | TSLP promotes immune evasion and persistence of viruses | Institut Curie (FR) | 2010-08-04 | — | — | EP | disclosed |
| US-20090186358-A1 | Pathway Analysis of Cell Culture Phenotypes and Uses Thereof | WYETH (US) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230054895-A1 | METHODS FOR INDUCING BIOSTASIS IN A CELL, TISSUE OR ORGAN | OPRL1, OPRK1, OPRD1 | P2RY1 2720/4885P2RY2 2896/4885SRC 2090/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.